Gynecomastia in Patients with Prostate Cancer: A Systematic Review.

<h4>Introduction</h4>Gynecomastia and/or mastodynia is a common medical problem in patients receiving antiandrogen (bicalutamide or flutamide) treatment for prostate cancer; up to 70% of these patients result to be affected; furthermore, this can jeopardise patients' quality of life...

Full description

Saved in:
Bibliographic Details
Main Authors: Anders Fagerlund, Luigi Cormio, Lina Palangi, Richard Lewin, Fabio Santanelli di Pompeo, Anna Elander, Gennaro Selvaggi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0136094&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850113687577165824
author Anders Fagerlund
Luigi Cormio
Lina Palangi
Richard Lewin
Fabio Santanelli di Pompeo
Anna Elander
Gennaro Selvaggi
author_facet Anders Fagerlund
Luigi Cormio
Lina Palangi
Richard Lewin
Fabio Santanelli di Pompeo
Anna Elander
Gennaro Selvaggi
author_sort Anders Fagerlund
collection DOAJ
description <h4>Introduction</h4>Gynecomastia and/or mastodynia is a common medical problem in patients receiving antiandrogen (bicalutamide or flutamide) treatment for prostate cancer; up to 70% of these patients result to be affected; furthermore, this can jeopardise patients' quality of life.<h4>Aims</h4>To systematically review the quality of evidence of the current literature regarding treatment options for bicalutamide-induced gynecomastia, including efficacy, safety and patients' quality of life.<h4>Methods</h4>The PubMed, Medline, Scopus, The Cochrane Library and SveMed+ databases were systematically searched between January 1, 2000 and December 31, 2014. All searches were undertaken between January and February 2015. The search phrase used was:"gynecomastia AND treatment AND prostate cancer". Two reviewers assessed 762 titles and abstracts identified. The search and review process was done in accordance with the PRISMA statement. The PICOS (patients, intervention, comparator, outcomes and study design) process was used to specify inclusion criteria. Quality of evidence was rated according to GRADE.<h4>Main outcome measures</h4>Primary outcomes were: treatment effects, number of complications and side effects. Secondary outcome was: Quality of Life.<h4>Results</h4>Eleven studies met the inclusion criteria and are analysed in this review. Five studies reported pharmacological intervention with tamoxifen and/or anastrozole, either as prophylactic or therapeutic treatment. Four studies reported radiotherapy as prophylactic and/or therapeutic treatment. Two studies compared pharmacological treatment to radiotherapy. Most of the studies were randomized with varying risk of bias. According to GRADE, quality of evidence was moderate to high.<h4>Conclusions</h4>Bicalutamide-induced gynecomastia and/or mastodynia can effectively be managed by oral tamoxifen (10-20 mg daily) or radiotherapy without relevant side effects. Prophylaxis or therapeutic treatment with tamoxifen results to be more effective than radiotherapy.
format Article
id doaj-art-f3ee9b60554b4bfd9c08d6ded8ac0b6c
institution OA Journals
issn 1932-6203
language English
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-f3ee9b60554b4bfd9c08d6ded8ac0b6c2025-08-20T02:37:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01108e013609410.1371/journal.pone.0136094Gynecomastia in Patients with Prostate Cancer: A Systematic Review.Anders FagerlundLuigi CormioLina PalangiRichard LewinFabio Santanelli di PompeoAnna ElanderGennaro Selvaggi<h4>Introduction</h4>Gynecomastia and/or mastodynia is a common medical problem in patients receiving antiandrogen (bicalutamide or flutamide) treatment for prostate cancer; up to 70% of these patients result to be affected; furthermore, this can jeopardise patients' quality of life.<h4>Aims</h4>To systematically review the quality of evidence of the current literature regarding treatment options for bicalutamide-induced gynecomastia, including efficacy, safety and patients' quality of life.<h4>Methods</h4>The PubMed, Medline, Scopus, The Cochrane Library and SveMed+ databases were systematically searched between January 1, 2000 and December 31, 2014. All searches were undertaken between January and February 2015. The search phrase used was:"gynecomastia AND treatment AND prostate cancer". Two reviewers assessed 762 titles and abstracts identified. The search and review process was done in accordance with the PRISMA statement. The PICOS (patients, intervention, comparator, outcomes and study design) process was used to specify inclusion criteria. Quality of evidence was rated according to GRADE.<h4>Main outcome measures</h4>Primary outcomes were: treatment effects, number of complications and side effects. Secondary outcome was: Quality of Life.<h4>Results</h4>Eleven studies met the inclusion criteria and are analysed in this review. Five studies reported pharmacological intervention with tamoxifen and/or anastrozole, either as prophylactic or therapeutic treatment. Four studies reported radiotherapy as prophylactic and/or therapeutic treatment. Two studies compared pharmacological treatment to radiotherapy. Most of the studies were randomized with varying risk of bias. According to GRADE, quality of evidence was moderate to high.<h4>Conclusions</h4>Bicalutamide-induced gynecomastia and/or mastodynia can effectively be managed by oral tamoxifen (10-20 mg daily) or radiotherapy without relevant side effects. Prophylaxis or therapeutic treatment with tamoxifen results to be more effective than radiotherapy.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0136094&type=printable
spellingShingle Anders Fagerlund
Luigi Cormio
Lina Palangi
Richard Lewin
Fabio Santanelli di Pompeo
Anna Elander
Gennaro Selvaggi
Gynecomastia in Patients with Prostate Cancer: A Systematic Review.
PLoS ONE
title Gynecomastia in Patients with Prostate Cancer: A Systematic Review.
title_full Gynecomastia in Patients with Prostate Cancer: A Systematic Review.
title_fullStr Gynecomastia in Patients with Prostate Cancer: A Systematic Review.
title_full_unstemmed Gynecomastia in Patients with Prostate Cancer: A Systematic Review.
title_short Gynecomastia in Patients with Prostate Cancer: A Systematic Review.
title_sort gynecomastia in patients with prostate cancer a systematic review
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0136094&type=printable
work_keys_str_mv AT andersfagerlund gynecomastiainpatientswithprostatecancerasystematicreview
AT luigicormio gynecomastiainpatientswithprostatecancerasystematicreview
AT linapalangi gynecomastiainpatientswithprostatecancerasystematicreview
AT richardlewin gynecomastiainpatientswithprostatecancerasystematicreview
AT fabiosantanellidipompeo gynecomastiainpatientswithprostatecancerasystematicreview
AT annaelander gynecomastiainpatientswithprostatecancerasystematicreview
AT gennaroselvaggi gynecomastiainpatientswithprostatecancerasystematicreview